Internal mammary artery aneurysms are rare but serious clinical entities. Rupture results in hemothorax and can be life threatening. Most reported cases are pseudoaneurysms secondary to iatrogenic or traumatic causes. Noniatrogenic, nontraumatic, true internal mammary artery aneurysms have most commonly been associated with vasculitides or connective tissue disorders; rare cases have been deemed idiopathic. We describe a rare case of bilateral internal mammary artery aneurysmsdsuccessfully treated with coil embolizationdin the setting of heterozygosity for a missense variant of unknown significance in the COL5A1 gene and multifocal fibrodysplastic changes on angiography. (J Vasc Surg Cases and Innovative Techniques 2019;5:410-4.) 
True internal mammary artery aneurysms are rare. The majority of published reports describe iatrogenic or traumatic pseudoaneurysms. 1 Only 14 cases to date have described noniatrogenic internal mammary artery aneurysms caused by vasculitides, connective tissue disorders, and rarely idiopathic etiology. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] Bilateral internal mammary artery aneurysms are even less common, with only two published reports, both describing patients with Marfan syndrome. 6, 9 Internal mammary artery aneurysms have traditionally been managed surgically, and endovascular repair has only recently been described. Herein, we present a rare case of bilateral internal mammary artery aneurysms treated simultaneously with transbrachial coil embolization in the setting of heterozygosity for a missense variant of unknown significance in COL5A1, and multifocal fibromuscular dysplasia (FMD). The patient described here has consented to publication of all case details and associated images.
CASE REPORT
Presentation. A 62-year-old man, former smoker (10 pack-year history), with no known history of vascular disease, trauma, or previous surgical procedures, presented to the emergency department with acute exacerbation of ongoing chest pain of 6 months' duration, worse with exertion. Acute coronary syndrome, pulmonary embolism, chronic obstructive pulmonary disease, and infectious etiologies were ruled out. Computed tomography angiography (CTA) revealed aneurysms in multiple arterial beds (Table and Fig 15, 16 dmultiple intercostal arteries, right subclavian artery (2.1 cm), celiac artery (1.4 cm), right renal artery, and bilateral iliac arteries (right 1.8 cm, left 2.4 cm). A "string-of-beads" appearance was noted in the intercostal arteries ( Fig 2, B ), suggestive of fibromuscular dysplasia, multifocal type. Given the patient's presenting symptoms as well as the size and saccular nature of the internal mammary artery aneurysms, treatment was warranted. The decision was made to proceed with a minimally invasive endovascular approach.
Surgical technique. Via retrograde transbrachial access, selective catheterization of the proximal subclavian arteries was performed bilaterally. Angiography was performed in multiple views confirming CTA findings (Fig 3, A) . Under roadmap guidance, a coaxial systemdcomprised of a 5F short sheath, a 5F C2 catheter (Cook Medical, Bloomington, Ind), and a 2.7F, 45 angled tip, high-flow Lantern microcatheter (Penumbra, Alameda, Calif)dwas used to selectively catheterize the distal outflow of the aneurysms bilaterally. Mechanically detachable Ruby POD and packing coils (Penumbra) were used to first form a distal plug, and then pack the outflow, sac, and inflow of aneurysms bilaterally with good deposition and no evidence of nontarget embolization (Fig 3, B ). No coil extrusion into the feeding subclavian arteries was noted. Aneurysm sac devascularization was confirmed on completion angiography at followup visits ( 
DISCUSSION
Limited literature exists regarding the etiology and management of true internal mammary artery aneurysms. Noniatrogenic cases have been attributed to connective tissue disorders including Marfan, Ehlers-Danlos, Loeys-Dietz, and SMAD3 mutation syndromes; in addition to other systemic vascular disorders including polyarteritis nodosa, FMD, and atherosclerosis. Only one other case of internal mammary artery aneurysm in a patient with FMD has previously been reported; and no treatment was undertaken in that report. 11 Presented here is an extremely rare case of bilateral internal mammary artery aneurysms in a 62-year-old man with angiographic evidence of multifocal FMD, as well as heterozygosity for a missense variant in COL5A1da gene implicated in Ehlers-Danlos syndrome with type V collagenopathy. This variant (p.C1746S), classified as a variant of unknown significance, has not been reported before in the general population and is located at a highly conserved residue in evolution. It results in the substitution of a cysteine residue by serine, which usually leads to failure of collagen chain incorporation into trimers. This variant is also predicted to be deleterious for protein function by online prediction tools. Although there is not enough evidence yet to prove this mutation is disease-causing, its rarity, location in a highly conserved region in evolution, and the fact that it is damaging to protein function point to probable pathogenicity. The patient's phenotype of multifocal aneurysmal disease could be explained by a disorder in the Ehlers-Danlos syndrome spectrum. Although COL5A1 is not implicated in vascular Ehlers-Danlos syndrome, 18 vascular phenotypes, including arterial aneurysms and dissections, have indeed been reported in classical Ehlers-Danlos syndrome. 19 This is the most likely etiology of the aneurysms, but the fibrodysplastic changes noted on CTA cannot be excluded from the differential diagnosis. A combined, multifactorial process is another rare but plausible explanation. Although no direct link has been definitively identified between FMD and collagenopathies of various sorts, such connections have been suggested. [20] [21] [22] [23] Genetic testing for vascular connective tissue disorders has had a low yield in FMD 24 and additional molecular research to elucidate the unique genetic and environmental factors associated with the pathogenesis of FMD is necessary.
Traditionally, sternotomy has been the therapeutic approach of choice for internal mammary artery aneurysms. 1, [12] [13] [14] More recently, less invasive embolotherapeutic techniques have been described. [2] [3] [4] [5] [6] [7] [8] [9] [10] Although our otherwise healthy patient may have been a candidate for potential open surgery, a minimally invasive approach was selected to minimize perioperative morbidity, particularly with the bilateral nature of his disease. A minimally invasive endovascular approach based on packing coils was safe and effective in eliminating flow through the aneurysm sacs in a durable manner. The completely detachable mechanism of releasedas opposed to partially detachable and/or pushable coilsd allows for maximal precision of deployment into ostial lesions at high risk for catastrophic nontarget embolization.
The treatment of bilateral internal mammary artery aneurysms has been reported twice, both in patients with Marfan syndrome and multiple previous thoracotomies for aortic repair. 6, 9 One patient was treated with placement of balloon-expandable stents across the internal mammary artery aneurysms, and the other with coil embolization. Both patients were treated in a staged fashion. To our knowledge, our report is the first to describe simultaneous embolization of bilateral internal mammary artery aneurysms using mechanically detachable coils.
Although less relevant in our patient with minimal risk factors and a negative cardiac evaluation, obliteration of the left internal mammary artery as a potential inflow source for coronary artery bypass grafting in the future is an important consideration with the currently described technique. In patients who have a cardiac history and who may require a coronary artery bypass graft in the future, preservation of the left internal mammary artery should be taken into consideration.
CONCLUSIONS
There are no established guidelines for the treatment of internal mammary artery aneurysms owing to their rarity. Increasingly, recent reports describe an endovascular approach as opposed to traditional open surgery. This report further suggests that simultaneous embolization of bilateral internal mammary artery aneurysms using mechanically detachable packing coils is safe, durable, and effective in appropriately selected patients at the 1year follow-up. Heterozygous variants of unknown significance can have clinical manifestations of the underlying collagenopathy that warrant surgical intervention. Further molecular investigation into possible links between FMD and various collagenopathies is warranted.
